Why is Onyx Biotec falling/rising?

As of 05-Aug, Onyx Biotec Ltd is experiencing a decline in its stock price, currently at 47.10, which represents a decrease of 1.4 or 2.89%. The stock has underperformed in the short term, with a 1-week return of -2.89%, matching its 1-month performance. Additionally, it is trading below all key moving averages, indicating a bearish trend. However, there has been a notable increase in investor participation, with delivery volume rising by 471.43% against the 5-day average, suggesting some interest despite the overall downward movement. Unfortunately, there is no information available regarding positive or negative factors that could further clarify the stock's recent performance.
In the broader market context, Onyx Biotec's recent performance contrasts with the benchmark, the Sensex, which has seen a smaller decline of 0.69% over the same week. While the stock has fallen significantly year-to-date by 20.84%, the Sensex has gained 4.25% in the same period, highlighting a stark divergence in performance. This underperformance against the benchmark may contribute to investor sentiment and the stock's current price decline.